Opexa Therapeutics to Present at the Merriman Curhan Ford & Co. 6th Annual Investor Summit 2009 on November 10, 2009

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a corporate presentation at the Merriman Curhan Ford 6th Annual Investor Summit 2009. The conference will be held November 9-10, 2009, at the Sofitel New York Hotel in New York City.